Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(50.0%)

Phase 2

2(33.3%)

N/A

1(16.7%)

6Total

Phase 1(3)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02444598Not ApplicableCompleted

Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds

Role: collaborator

NCT02519582Phase 2Unknown

Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy

Role: collaborator

NCT00005939Phase 1Unknown

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

Role: lead

NCT00004129Phase 1Unknown

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

Role: lead

NCT00006212Phase 1Unknown

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Role: lead

NCT00002689Phase 2Completed

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

Role: lead

All 6 trials loaded